Trump's Speech Drives Crude Prices Up to $110
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly.WAR ON IRAN:President Donald Trump addressed the nation last night. The speech focused on the conflict with Iran, with Trump emphasizing continued military action over the coming weeks rather than de-escalation. Crude prices surged back above $100 and pushed toward $110 as fears continue to grow over sustained interruption in the Strait of Hormuz.DEFENSE CONTRACTOR SECTOR:The Middle East conflict promises to inject additional cash into the defense contractor sector as the U.S. and its allies look to refill their weapon stockpiles, Sylvia Pfiefer, Christian Davies, and Steff Chavex of The Financial Times. In Washington, the Trump admin is planning to request Congress for $1.5T in defense spending for the year, with the Pentagon asking the White House to submit a request to Congress for an extra $200B to help fund the war in Iran at the same time. While there is no certainty these requests will be approved, it is clear the war has depleted stockpiles of America's missile and air defense systems built by RTXand Lockheed Martin.PHARMACEUTICAL TARIFFS:The Trump administration is preparing 100% tariffs on certain imported medicines, targeting companies that have not committed to increasing U.S. manufacturing, The Financial Times' Aime Williams. The move follows earlier threats to impose such levies on branded or patented drugs, while companies including Pfizer, AstraZeneca, and Novo Nordiskhave secured exemptions by pledging greater U.S. investment and price reductions. Other publicly traded companies in the space include Bristol Myers, Eli Lilly, GSK, Johnson & Johnson, Merck, Novartis, Rocheand Sanofi.DRUG PRICING DEALS INTO LAW:Eli Lilly opposes the White House's push to codify "most favored nation" drug pricing into law, CEO Dave Ricks said in an interview with. Lilly is one of more than a dozen drugmakers that signed deals with the Trump administration last year agreeing to charge similar prices for prescription drugs in the U.S. as other wealthy nations, CNBC's Angelica Peebles notes. "When you throw it into the congressional process, what goes in is not what's going to come out," Ricks said. Ricks said he thinks the Trump administration and leadership on the Hill are listening to the company's concerns, but he said Lilly will use "all the tools we have to combat bad policy, and we think it would be bad policy."STEEL/ALUMINUM TARIFF:Trump administration is set to modify duties on imported steel and aluminum finished products to help simplify compliance with a 25% tariff, the Wall Street Journal's Gavin Bade and Bob Tita, citing people with knowledge of the plans. The 25% tariff would apply to the entire value of a finished product containing steel and aluminum and replace the current 50% duty, which only applies to the value of steel or aluminum used in a product, which could effectively raise costs for many imports, the report stated. Publicly traded companies in the Steel space include ArcelorMittal, Cleveland-Cliffs, Nucor, Steel Dynamicsand U.S. Steel. Public companies in Aluminum include Alcoa, Century Aluminum, and Kaiser Aluminum.
Trade with 70% Backtested Accuracy
Analyst Views on SPXC
About SPXC
About the author

- Honeywell Upgrade: BMO has upgraded Honeywell to Outperform, citing additional opportunities through the end of the decade; despite lagging shares, the company's strong balance sheet provides downside protection and supports upcoming spin-offs.
- Disney Outlook: Wells Fargo reiterates Disney as Overweight, lowering its price target to $148 but highlighting the new leadership team's potential to revitalize the narrative, making Q2 a pivotal moment for growth acceleration.
- Knight-Swift Upgrade: Evercore ISI has upgraded Knight-Swift to Outperform, viewing the transport company as compelling due to its leverage to improving fundamentals, while trading at one of the lowest multiples in its peer group.
- FuboTV Initiation: B Riley initiates coverage of FuboTV with a Buy rating and a target price of $18, emphasizing the stock's undervaluation and its potential in the consumer live television streaming market.
Technological Advances: The rise of new technologies is influencing various sectors, particularly in security and trust.
Market Trends: There is a growing trend for companies to buy from established holders in the market, indicating a shift in purchasing strategies.
- nLIGHT Coverage Initiation: Baird initiates coverage of nLIGHT with an Outperform rating and a $95 price target, citing favorable market trends and robust funding that support growth, particularly enhanced by the company's vertical integration and technological strengths.
- Apple's New Product Launch: Oppenheimer reiterates Apple as Perform, highlighting the new MacBook Pro lines powered by M5 Pro and M5 Max chips, which signify a new era of local AI computing and reinforce Apple's significant lead in efficiency and scalability in personal computing devices.
- PulteGroup and Toll Brothers Ratings: Truist initiates PulteGroup and Toll Brothers with Buy ratings, setting a price target of $170, as they believe the market is significantly undervaluing both companies' profitability potential, especially in the context of a recovering luxury housing market.
- Tesla and General Motors Upgrades: Bank of America upgrades Tesla to Buy with a $460 price target, viewing it as the leader in consumer autonomy, while reinstating General Motors as Buy, expecting benefits from lower warranty costs and regulatory credits.
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several stocks, including upgrades, downgrades, and initiations, reflecting varying market perspectives and future expectations for these companies.
- Market Dynamics Overview: While specific stock names are not mentioned, changes in analyst ratings typically influence investor decisions, potentially leading to price volatility in the affected stocks.
- Investor Focus: For those considering buying SPXC stock, analysts' opinions may provide crucial insights, helping them assess potential investment risks and returns.
- Source of Information: This information is provided by Benzinga, highlighting the significance of analyst ratings in investment decisions, and investors should monitor these changes to optimize their portfolios.

- Stock Sale Announcement: Officer Lowe Eugene Joseph III plans to sell 41,416 shares of SPX Technologies' common stock.
- Market Value: The total market value of the shares to be sold is approximately $9.33 million.
- Strong Earnings Growth: SPX Technologies reported an adjusted EPS of $1.88 for Q4 2025, with a full-year adjusted EPS growth of 21% to $6.76, demonstrating sustainable profitability driven by robust market demand.
- Strategic Acquisition Strengthening: The recent acquisitions of Thermolec, Air Enterprises, and Rahn Industries enhance the company's position in the electric heat and engineered air movement markets, with HVAC segment revenue expected to rise to between $1.8 billion and $1.84 billion.
- Optimistic Future Outlook: Management anticipates approximately 20% growth in adjusted EBITDA for 2026, setting revenue targets between $2.535 billion and $2.605 billion, reflecting strong confidence in future market demand.
- Cash Flow and Debt Management: The company achieved an adjusted free cash flow of $294 million for the year, with cash reserves of $366 million and total debt of $502 million, resulting in a leverage ratio of approximately 0.3x, indicating solid financial health during expansion.








